Filing Details
- Accession Number:
- 0001140361-12-015521
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-14 16:10:35
- Reporting Period:
- 2012-03-13
- Filing Date:
- 2012-03-14
- Accepted Time:
- 2012-03-14 16:10:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 737572 | Elan Corp Plc | Treasury Building Lower Grand Canal Street Dublin 2 L2 00000 | No | No | Yes | No | |
| 1530023 | Ltd Three Science Elan | Treasury Building Lower Grand Canal Street Dublin 2 L2 00000 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2012-03-13 | 24,150,000 | $15.80 | 7,750,000 | No | 4 | S | Indirect | Indirect |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | Indirect |
Footnotes
- These shares were sold by Elan Science Three Limited ("ES3") in a marketed underwritten registered offering pursuant to a shelf registration statement on Form S-1 filed by Alkermes plc with the Securities and Exchange Commission (the "SEC"), which the SEC declared effective March 2, 2012 (File No. 333-179550).
- Represents a price to the public of $16.50 per ordinary share less the underwriting discount.
- Shares directly owned by ES3. ES3 is an indirect, wholly-owned subsidiary of Elan Corporation, plc.
Billionaire Hedge Funds
